Why the study?
Although epidemiologic studies suggest dyslipidemia increases colorectal cancer risk, the prognostic value of blood lipid and apolipoprotein levels in colorectal cancer remains unclear.
Do high preoperative triglyceride and apolipoprotein B levels predict worse disease-free and overall survival in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery?
Do high preoperative triglyceride and apolipoprotein B levels predict worse disease-free and overall survival in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery?
High preoperative triglyceride and apolipoprotein B levels are independent prognostic biomarkers for decreased disease-free and overall survival in patients undergoing radical colorectal cancer surgery.
No takes yet. Share an insight, caveat, or question.
May inform preoperative risk stratification in stage II-III CRC; hypothesis-generating for lipid-targeted trials.
Chen et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: